On February 22, 2023, the U.S. Department of Justice (“DOJ”) issued a corporate Voluntary Self-Disclosure policy (the “Policy”) that applies to all United States Attorney’s Offices (“USAOs”), effective immediately. The articulated goal... Read More
On January 30, 2023, the Biden Administration announced that the COVID-19 Public Health Emergency (“PHE”), which has been in effect since January 2020, is set to expire on May 11, 2023. Considering the impending end to the PHE, healthcare... Read More
As physician practices are in the midst of calculating and distributing 2022 year-end bonuses to physician employees and profits to owners, practices providing Designated Health Services ("DHS"), such as laboratory testing, diagnostic radiology... Read More
During the 2021 fiscal year, The U.S. Department of Justice (DOJ) recovered $5.6 billion in civil settlements and judgments involving fraud and violations of the False Claims Act; a record-breaking $5 billion of this recovery was derived from... Read More
Earlier this month, a Joint Stipulation of Dismissal was filed on behalf of a management company and several anesthesiologists, gastroenterologists, an affiliated professional services corporation, and various ambulatory surgery center defendants... Read More
Frier Levitt healthcare partners Daniel B. Frier, Esq. and Michelle L. Greenberg, Esq. authored an article for the November/December 2021 Edition of ASC Focus titled, "How to Handle Improper Physician Conduct". "Perhaps more than any other... Read More
In what may be the first of many lawsuits, a New Mexico county prison guard has filed a lawsuit challenging a directive requiring all first responders to receive a COVID-19 vaccine as a condition of continued employment. The lawsuit is particularly... Read More
By Jonathan E. Levitt, Esq. The Office of Inspector General (OIG) submits semiannual reports to Congress, summarizing the activities of the OIG and the Department of Health and Human Services. In its Reports, the OIG proposes improvements it deems... Read More
